杏吧论坛

Blog

FDA鈥檚 New QMSR Final Rule: What Medical Device Manufacturers Need to Know (2026)


The FDA鈥檚 replaces the legacy QSR and formally incorporates ISO 13485:2016 (and ISO 9000:2015 Clause 3 for terminology) by reference. The final rule was issued on February 2, 2024, with an effective date of February 2, 2026 and it arrives with a new, lifecycle鈥慺ocused inspection model that retires QSIT.

 

Why did FDA replace QSR with QMSR?

For nearly three decades, manufacturers managed a U.S. QSR that diverged from global practice, creating duplicate compliance burdens. QMSR harmonizes with ISO 13485, modernizes expectations, and preserves specific U.S. obligations where needed, improving clarity while reducing redundancy for firms marketing in multiple jurisdictions.

The headline changes you鈥檒l notice

ISO 13485 becomes the backbone of U.S. device CGMPs

QMSR restructures Part 820 to function as an overlay on ISO 13485:2016 (and ISO 9000:2015 for definitions), while retaining targeted FDA additions to avoid conflicts with U.S. requirements (e.g., records and labeling/packaging clarifications).

New inspection model; QSIT is retired

On the effective date, FDA begins inspections under Compliance Program 7382.850 and discontinues QSIT. Expect risk鈥慴ased planning, integration of post-market and lifecycle data, and inspectors following issues across processes rather than auditing subsystems in isolation.

Analyses show FDA will organize inspections around six QMS Areas and cover four 鈥淥ther Applicable FDA Requirements鈥 (MDR, Corrections/Removals, Tracking, UDI), often starting with your risk management file as the roadmap.

Terminology alignment: DHF/DMR/DHR 鈫 ISO terms

QMSR sunsets QSR鈥憃nly terms in favor of ISO vocabulary:

  • Design History File (DHF) 鈫 Design & Development File (DDF)
  • Device Master Record (DMR) 鈫 Medical Device File (MDF)
  • Design History Record (DHR) 鈫 Manufacturing Records/Records

FDA notes the content obligations remain under ISO clauses (especially 4.2 and 7.x) and retaining the old terms would be redundant and confusing.

Practical tip: You don鈥檛 have to rename every document, just ensure your files demonstrably meet ISO 13485 content and traceability, and keep a clear mapping for inspection.

Internal audits & management reviews are now fair game

Under QMSR and its new compliance program, industry observers and FDA鈥慺acing legal analysts note that internal audits, supplier audits, and management review records are no longer categorically exempt. Treat them as 颈苍蝉辫别肠迟颈辞苍鈥憆别补诲测 evidence.

MDSAP updates and new home

The MDSAP Audit Approach has been updated to Version 10 and is now hosted on MDSAP. Global, managed by Australia鈥檚 TGA, important for firms relying on MDSAP for global oversight alignment.

What doesn鈥檛 change鈥攁nd where FDA adds clarity

QMSR supplements rather than displaces certain U.S. obligations. You should continue to reference UDI (21 CFR Part 830) and Medical Device Tracking (21 CFR Part 821) where ISO 13485鈥檚 text isn鈥檛 sufficiently specific for U.S. needs. FDA鈥檚 Part 820 overlay also emphasizes records and labeling/packaging controls to ensure U.S. expectations remain explicit.

Design controls under QMSR: clarifying Class I and risk

Class I exemptions: If your device was previously exempt from design controls, that status remains; QMSR doesn鈥檛 retroactively impose design controls on exempt devices. (Narrow exceptions for specific Class I products continue as before.)

Risk integration: Inspectors now begin with your risk management documentation and trace how risks drive design decisions, supplier oversight, production controls, and post-market actions reflecting the ISO 13485/ISO 14971 emphasis and the new compliance program鈥檚 lifecycle scope.

Inspections under CP 7382.850: what FDA evaluates now

FDA will test whether your QMS works as an integrated, risk鈥慸riven whole:

  • Risk鈥慴ased sampling guided by your risk files; investigators follow issues across functions.
  • Lifecycle data integration (complaints, MDRs, recalls, servicing, supplier issues) feeding back into design/manufacturing changes.
  • Six QMS Areas + four OAFRs (MDR, Corrections/Removals, Tracking, UDI) form the backbone of inspection scope.

Do I have to buy ISO 13485 now?

Because QMSR incorporates ISO 13485 by reference, firms need to control the standard as an external document inside their QMS, typically requiring purchase and version control (per ISO 13485 clause 4.2.4 on external documents).

If you鈥檙e already ISO 13485鈥慶ertified: the lift is manageable

Most of the effort is validating coverage of the Part 820 overlay and tightening traceability to U.S. obligations (MDR, UDI, tracking, labeling controls). Expect incremental updates for servicing/installation records and labeling release/reconciliation to match FDA clarity.

FAQs

Q: Does QMSR change Class I design control exemptions?
A: No. Devices previously exempt remain exempt (with the same narrow exceptions).

Q: Does ISO 13485 certification replace FDA inspections?
A: No. FDA still inspects under QMSR and CP 7382.850; certification helps, but it鈥檚 not a substitute.

Q: Do we have to rename DHF/DMR/DHR?
A: Not necessarily. Ensure your content satisfies ISO 13485, maintain a clear mapping, and be consistent in training and retrieval.

How 杏吧论坛 Can Support Your QMSR Transition

The shift from QSR to QMSR is more than a terminology update, it鈥檚 a transformation in how quality systems are evaluated. With ISO 13485 as the legal backbone of Part 820 and a risk鈥慴ased, lifecycle inspection model replacing QSIT, the standard is clear: demonstrate real鈥憌orld system effectiveness.

Why partner with 杏吧论坛 now?

  • QMSR Gap Assessment & Implementation Support鈥攎ap current QSR systems to ISO 13485 + FDA overlay (records, labeling/packaging).
  • SOP & Document Modernization鈥攁lign MDF/D&D files and manufacturing records with 颈苍蝉辫别肠迟颈辞苍鈥憆别补诲测 ISO/FDA expectations.
  • Risk Management Integration鈥攅mbed ISO 14971 across design, suppliers, production, and post-market鈥攖he first stop for investigators.
  • Mock FDA Inspections (CP 7382.850)鈥攖rain on the new lifecycle framework (risk鈥慴ased sampling; six QMS Areas + OAFRs).
  • MDSAP Alignment鈥攗pdate readiness to MDSAP Audit Approach v10 (MDSAP.Global).

Ready to strengthen your quality system and prepare for QMSR?

Contact 杏吧论坛 today to schedule a QMSR readiness review or request a customized support plan. Your next inspection will test how your system performs, not just what鈥檚 on paper.

Connect with 杏吧论坛 Today

Contact us to learn more about our regulatory compliance experts and how they can help

    Footer artwork